Takeda, Brii Biosciences and Dr. Reddy s Laboratories made our news this week. (Google)
Takeda is buying its partner Maverick Therapeutics for its T-cell engager platform. The NIH has ended a clinical study testing Brii Biosciences anti-coronavirus antibody cocktail in hospitalized patients. Dr. Reddy s Laboratories is pulling a large volume of its generic Lipitor off U.S. pharmacy shelves due to impurities. And more.
Takeda exercised an option to buy out Maverick Therapeutics as part of a collaboration deal penned in early 2017. For up to $525 million upfront, Takeda’s getting full control of Maverick’s COBRA T-cell engager platform and the cancer pipeline built around it. These assets include lead candidate MVC-101, now known as TAK-186, which is in a phase 1/2 study in solid tumors that express EGFR.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Novus Capital Appoints Two New Board Advisors
March 12, 2021 GMT
INDIANAPOLIS (BUSINESS WIRE) Mar 12, 2021
Novus Capital, a company focused on sustainability and social equity through technological innovation, announces two new Board Advisors: Lacy M. Johnson and Ittai Kidron.
“Novus Capital’s Board and Board Advisors play a vital role in guiding our partners through strategic, operational and regulatory considerations,” said Bob Laikin, co-founder of Novus Capital. “Lacy and Ittai bring a depth of experience, and we’re proud to welcome them.”
Lacy M. Johnson is a partner in Taft Stettinius & Hollister LLP’s Public Affairs Strategies Group and partner-in-charge of the firm’s Washington D.C. office. He is a preeminent senior lawyer, having served on the Biden-Harris transition team, and was a member of Vice President Harris’s Midwest Finance team. He is a trusted advi
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Software Acquisition Group Inc. II Announces Filing of Registration Statement on Form F-4 by .
OtonomoMarch 12, 2021 GMT
Herzliya, Israel and Las Vegas, Nevada, March 12, 2021 (GLOBE NEWSWIRE) Software Acquisition Group Inc II (NASDAQ: SAII) (“Software Acquisition Group”), a US publicly-traded special purpose acquisition company, announced today that Otonomo Technologies Ltd. (“Otonomo”) has filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form F-4 (the “Registration Statement”), which contains a preliminary proxy statement/prospectus, in connection with Software Acquisition Group’s recently-announced proposed business combination with Otonomo, the premier one-stop shop for vehicle data. The board of the directors of the combined company will include Jonathan Huberman, Software Acquisition Group’s CEO. While the Registrati
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Bonanza Creek Energy, Inc. and HighPoint Resources Announce Final Results of Exchange Offer and .
HighPoint Resources CorporationMarch 12, 2021 GMT
DENVER, March 12, 2021 (GLOBE NEWSWIRE) Bonanza Creek Energy, Inc. (NYSE: BCEI) (the “Company” or “Bonanza Creek”) and HighPoint Resources Corporation (“HighPoint”) (NYSE: HPR) today announced the expiration and results of Bonanza Creek’s previously announced offer to exchange (the “Exchange Offer”) shares of its common stock and newly issued 7.5% Senior Notes due 2026 (the “Bonanza Creek Senior Notes”) for any and all of the 7.0% Senior Notes due October 15, 2022 (the “2022 Notes”) of HighPoint Operating Corporation (“HighPoint OpCo”) and the 8.75% Senior Notes due June 15, 2025 of HighPoint OpCo (the “2025 Notes” and, together with the 2022 Notes, the “HighPoint Senior Notes”) as of 5:00 p.m. New York